Cite

    C. Besson et al.. “Retrospective analysis of bevacizumab use in combination with irinotecan for recurrent glioblastoma: a single-institution experience.” European journal of cancer, vol. 72, n.d., pp. S48–. http://access.bl.uk/ark:/81055/vdc_100041522076.0x000056